Falling between the cracks: a case of amiodarone toxicity.
作者信息
Mackenzie Constanze, Syed Jaffer, Pollak P Timothy, Koren Gideon
机构信息
Department of Clinical Pharmacology and Respirology, University of Western Ontario, London, Ont.
出版信息
CMAJ. 2011 Sep 6;183(12):1393-7. doi: 10.1503/cmaj.100351. Epub 2011 Jul 11.
Abstract
摘要
相似文献
1
Falling between the cracks: a case of amiodarone toxicity.被忽视：一例胺碘酮中毒病例
CMAJ. 2011 Sep 6;183(12):1393-7. doi: 10.1503/cmaj.100351. Epub 2011 Jul 11.
2
Amiodarone induced pulmonary toxicity in a case of atrial fibrillation.胺碘酮在一例心房颤动患者中引发了肺毒性。
J Assoc Physicians India. 2014 Apr;62(4):347-9.
3
Amiodarone for atrial fibrillation.用于心房颤动的胺碘酮。
N Engl J Med. 2007 Jun 7;356(23):2424-6; author reply 2424-6.
4
[Amiodarone treatment against atrial fibrillation caused thyrotoxicosis].胺碘酮治疗房颤所致甲状腺毒症
Lakartidningen. 2005;102(16):1231-3.
5
In response to "Anaphylaxis during intravenous administration of amiodarone": is amiodarone the best choice for management of atrial fibrillation?针对“静脉注射胺碘酮期间发生过敏反应”：胺碘酮是治疗心房颤动的最佳选择吗？
Ann Card Anaesth. 2014 Jan-Mar;17(1):70-1. doi: 10.4103/0971-9784.124153.
6
Amiodarone for atrial fibrillation.用于心房颤动的胺碘酮。
N Engl J Med. 2007 Jun 7;356(23):2424-6; author reply 2424-6. doi: 10.1056/NEJMc070876.
7
Amiodarone for atrial fibrillation.用于心房颤动的胺碘酮。
N Engl J Med. 2007 Jun 7;356(23):2424-6; author reply 2424-6.
8
Amiodarone for atrial fibrillation.用于心房颤动的胺碘酮。
N Engl J Med. 2007 Jun 7;356(23):2424-6; author reply 2424-6.
9
Amiodarone versus sotalol for atrial fibrillation.胺碘酮与索他洛尔治疗心房颤动的比较。
N Engl J Med. 2005 Aug 11;353(6):627-30; author reply 627-30. doi: 10.1056/NEJM200508113530618.
10
Amiodarone versus sotalol for atrial fibrillation.胺碘酮与索他洛尔治疗心房颤动的比较。
N Engl J Med. 2005 Aug 11;353(6):627-30; author reply 627-30.
引用本文的文献
1
Pulmonary Fibrosis Related to Amiodarone-Is It a Standard Pathophysiological Pattern? A Case-Based Literature Review.胺碘酮相关的肺纤维化——它是一种标准的病理生理模式吗？基于病例的文献综述。
Diagnostics (Basel). 2022 Dec 19;12(12):3217. doi: 10.3390/diagnostics12123217.
2
The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.胸部计算机断层扫描评分在评估胺碘酮所致肺毒性中的诊断效用。
Korean J Intern Med. 2014 Nov;29(6):746-53. doi: 10.3904/kjim.2014.29.6.746. Epub 2014 Oct 31.
3
Amiodarone-related thyroid dysfunction.胺碘酮相关的甲状腺功能障碍。
Intern Emerg Med. 2014 Dec;9(8):829-39. doi: 10.1007/s11739-014-1140-1. Epub 2014 Oct 28.
4
Acute amiodarone pulmonary toxicity following lung resection.肺切除术后急性胺碘酮肺毒性
Int J Biomed Sci. 2014 Sep;10(3):217-20.
本文引用的文献
1
Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II).1991 年至 2007 年抗心律失常药物的应用：来自加拿大心房颤动注册研究（CARAF I 和 II）的见解。
Heart Rhythm. 2010 Sep;7(9):1171-7. doi: 10.1016/j.hrthm.2010.04.026. Epub 2010 Apr 27.
2
Information exchange among physicians caring for the same patient in the community.社区中为同一患者提供护理的医生之间的信息交流。
CMAJ. 2008 Nov 4;179(10):1013-8. doi: 10.1503/cmaj.080430.
3
Amiodarone hepatotoxicity.胺碘酮肝毒性。
Curr Vasc Pharmacol. 2008 Jul;6(3):228-36. doi: 10.2174/157016108784912019.
4
Amiodarone-induced pulmonary toxicity.胺碘酮所致肺毒性。
Br J Clin Pharmacol. 2008 Jul;66(1):82-7. doi: 10.1111/j.1365-2125.2008.03177.x. Epub 2008 May 6.
5
Prescribing amiodarone: an evidence-based review of clinical indications.胺碘酮的处方开具：基于证据的临床适应证综述
JAMA. 2007 Sep 19;298(11):1312-22. doi: 10.1001/jama.298.11.1312.
6
A practical guide for clinicians who treat patients with amiodarone: 2007.2007年胺碘酮治疗患者临床实用指南。
Heart Rhythm. 2007 Sep;4(9):1250-9. doi: 10.1016/j.hrthm.2007.07.020. Epub 2007 Jul 20.
7
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.美国心脏病学会/美国心脏协会/欧洲心脏病学会2006年心房颤动患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南委员会（修订2001年心房颤动患者管理指南写作委员会）报告：与欧洲心律协会和心律协会合作制定。
Circulation. 2006 Aug 15;114(7):e257-354. doi: 10.1161/CIRCULATIONAHA.106.177292.
8
Adherence to the NASPE guideline for amiodarone monitoring at a medical university.一所医科大学对胺碘酮监测的NASPE指南的依从性。
J Manag Care Pharm. 2006 Apr;12(3):254-9. doi: 10.18553/jmcp.2006.12.3.254.
9
Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions.长期接受胺碘酮治疗的患者发生尖端扭转型室速：相关因素及药物相互作用
Isr Med Assoc J. 2005 Mar;7(3):163-5.
10
Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice.全科医疗中开具潜在危险/禁忌药物组合的发生率及可能原因。
Drug Saf. 2005;28(1):67-80. doi: 10.2165/00002018-200528010-00005.
Zotero 插件